Relapse After Early-Stage, Favorable Hodgkin Lymphoma With Conventional or High-Dose Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy
J. Clin. Oncol 2020 Oct 15;[EPub Ahead of Print], PJ Bröckelmann, H Müller, T Guhl, K Behringer, M Fuchs, AA Moccia, A Rank, M Soekler, T Vieler, T Pabst, C Baues, B von Tresckow, P Borchmann, A EngertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.